The DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessAbstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 2
- Luyten, 2001, Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age, Arthritis Rheum., 44, 85, 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6 · doi:10.1002/1529-0131(200101)44:1<85::aid-anr12>3.0.co;2-6
- Litwack, G. (2008). Human Biochemistry and Disease, Academic Press.
Cited by
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
“11 In other words, stem cell-derived exosomes (SC-Exo) inherit similar therapeutic effects from their parental cell of origin, e.g., anti-in fl ammation, immunomodulation and tissue regeneration.”
BackgroundConcise Review: Mesenchymal Stem Cells: From Roots to Boost
Andrzejewska, A., Lukomska, B., & Janowski, M. (2019) · Stem Cells · doi:10.1002/stem.3016 · Cited by 611
Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning
Ferreira, J. R., Teixeira, G. Q., Santos, S. G., Barbosa, M. A., Almeida-Porada, G., & Gonçalves, R. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02837 · Cited by 572
Harrell, C., Fellabaum, C., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8050467 · Cited by 501
“When MSCs are cultured in the presence of high concentration of inflammatory cytokines and engraft in the inflammatory microenvironment, they start to produce anti-angiogenic molecules in order to prevent migration of circulating leucocytes in the inflamed tissues [37].”
BackgroundInfluentialMesenchymal stromal/stem cell (MSC)-Derived exosomes in clinical trials
Lotfy, A., AboQuella, N. M., & Wang, H. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03287-7 · Cited by 482
“Additionally, several preclinical studies have reported that MSC-Exos therapy is superior compared to cell therapy in terms of safety, efficacy, and versatility [95, 96].”
BackgroundMesenchymal stem cell-derived exosomes for clinical use
Mendt, M., Rezvani, K., & Shpall, E. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0616-z · Cited by 465
Matas, J., Orrego, M., Amenabar, D., Infante, C., Tapia-Limonchi, R., Cadiz, M. I., Alcayaga-Miranda, F., González, P. L., Muse, E., Khoury, M., et al. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0053 · Cited by 413
Cofano, F., Boido, M., Monticelli, M., Zenga, F., Ducati, A., Vercelli, A., & Garbossa, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112698 · Cited by 398
“example, by inhibiting the release of pro-inflammatory cytokines (as interferon-γ and tumor necrosis factor α) or increasing the release of anti-inflammatory IL-10 [44,65].”
BackgroundInfluentialCosta, L. A., Eiro, N., Fraile, M., Gonzalez, L. O., Saá, J., Garcia-Portabella, P., Vega, B., Schneider, J., & Vizoso, F. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03600-0 · Cited by 313
Self-citationExtracellular microvesicles/exosomes: discovery, disbelief, acceptance, and the future?
Ratajczak, M. Z., & Ratajczak, J. (2020) · Leukemia · doi:10.1038/s41375-020-01041-z · Cited by 294
Samaeekia, R., Rabiee, B., Putra, I., Shen, X., Park, Y. J., Hematti, P., Eslani, M., & Djalilian, A. R. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-24803 · Cited by 281
“Exosomes can be isolated readily through centrifugation techniques, providing the benefits of MSC-mediated paracrine repair without the risk of immunological rejection, malignant transformation, and obstruction of small vessels associated with cell therapy.(13) They can be safely stored as they have excellent stable c…”
BackgroundBjørge, I. M., Kim, S. Y., Mano, J. F., Kalionis, B., & Chrzanowski, W. (2018) · Biomaterials Science · doi:10.1039/c7bm00479f · Cited by 275
Mitochondrial transfer/transplantation: an emerging therapeutic approach for multiple diseases
Liu, Z., Sun, Y., Qi, Z., Cao, L., & Ding, S. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00805-7 · Cited by 231
“In addition, transplanted stem cells deliver mitochondria and contain a large number of bioactive substances [95], which may work synergically with mitochondria.”
BackgroundEmergence of the Stem Cell Secretome in Regenerative Engineering
Daneshmandi, L., Shah, S., Jafari, T., Bhattacharjee, M., Momah, D., Saveh-Shemshaki, N., Lo, K. W.-H., & Laurencin, C. T. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2020.04.013 · Cited by 224
“The therapeutic effects of stem cells are regulated by three main mechanisms: homing, that is, migration to the site of injury; differentiation into various cell types that can engraft to the damaged tissue for repair; and secretion of bioactive factors [18].”
BackgroundTherapeutic applications of adipose cell-free derivatives: a review
Cai, Y., Li, J., Jia, C., He, Y., & Deng, C. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01831-3 · Cited by 210
“Reportedly, paracrine cytokines, exosomes, and other active substances are the main factors through which ADSCs exert their biological effects [11, 12].”
BackgroundShin, S., Lee, J., Kwon, Y., Park, K.-S., Jeong, J.-H., Choi, S.-J., Bang, S. I., Chang, J. W., & Lee, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020845 · Cited by 208
“A close correlation between the therapeutic efficacy of MSCs and the secreted biomolecules, including extracellular vesicles, is widely known [41].”
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas
Yu, F.-S. X., Lee, P. S. Y., Yang, L., Gao, N., Zhang, Y., Ljubimov, A. V., Yang, E., Zhou, Q., & Xie, L. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101039 · Cited by 200
Li, J., Xue, H., Li, T., Chu, X., Xin, D., Xiong, Y., Qiu, W., Gao, X., Qian, M., Xu, J., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.005 · Cited by 209
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
“Firstly, it is crucial to establish GMP guidelines for large-scale manufacturing of MSC-derived products [206,241,242].”
Current Advancements in Spinal Cord Injury Research—Glial Scar Formation and Neural Regeneration
Clifford, T., Finkel, Z., Rodriguez, B., Joseph, A., & Cai, L. (2023) · Cells · doi:10.3390/cells12060853 · Cited by 197
Advances in regenerative therapy: A review of the literature and future directions
Ntege, E. H., Sunami, H., & Shimizu, Y. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.01.004 · Cited by 194
Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair
Ahangar, P., Mills, S. J., & Cowin, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197038 · Cited by 183
“MSC-S therapy avoids the difficulties associated with live-cell administration in stem cells as well as advantages of ease of mass production, packaging and transportation [62].”
BackgroundInfluentialKim, H. Y., Kumar, H., Jo, M.-J., Kim, J., Yoon, J.-K., Lee, J.-R., Kang, M., Choo, Y. W., Song, S. Y., Kwon, S. P., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01816 · Cited by 190
Fujita, Y., Kadota, T., Araya, J., Ochiya, T., & Kuwano, K. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100355 · Cited by 188
“Indeed, it has been reported that <1% of MSCs survive for more than one week after systemic administration [53,54], suggesting that the main effects of MSCs are probably mediated by paracrine mechanisms [55,56].”
BackgroundMűzes, G., & Sipos, F. (2022) · Cells · doi:10.3390/cells11152300 · Cited by 168
“MSCs produce more immunomodulatory factors in three-dimensional (3D) cultures [59].”
BackgroundAdipose tissue stem cells in regenerative medicine
Miana, V. V., & Prieto González, E. A. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.822 · Cited by 175
Liu, L., Guo, S., Shi, W., Liu, Q., Huo, F., Wu, Y., & Tian, W. (2021) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0141 · Cited by 176
“9 It has been proven that the conditioned medium of BMSCs can promote periodontal tissue regeneration.”
Miceli, V., Bulati, M., Iannolo, G., Zito, G., Gallo, A., & Conaldi, P. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020763 · Cited by 175
“MSCs became very appealing because of the clinical promise for tissue repair in regenerative medicine [52] and, for that reason, they are used in a high number of clinical trials [28].”
BackgroundTargeting strategies for bone diseases: signaling pathways and clinical studies
Xu, H., Wang, W., Liu, X., Huang, W., Zhu, C., Xu, Y., Yang, H., Bai, J., & Geng, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01467-8 · Cited by 162
Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy
(2018) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.05.004 · Cited by 161
Recent advances and challenges in the recovery and purification of cellular exosomes
Ayala‐Mar, S., Donoso‐Quezada, J., Gallo‐Villanueva, R. C., Pérez‐González, V. H., & González‐Valdez, J. (2019) · Electrophoresis · doi:10.1002/elps.201800526 · Cited by 164
Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review
Ng, C. Y., Kee, L. T., Al-Masawa, M. E., Lee, Q. H., Subramaniam, T., Kok, D., Ng, M. H., & Law, J. X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147986 · Cited by 165
Ma, Z.-J., Yang, J.-J., Lu, Y.-B., Liu, Z.-Y., & Wang, X.-X. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i8.814 · Cited by 155
Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation
Silachev, D., Goryunov, K., Shpilyuk, M., Beznoschenko, O., Morozova, N., Kraevaya, E., Popkov, V., Pevzner, I., Zorova, L., Evtushenko, E., et al. (2019) · Cells · doi:10.3390/cells8030258 · Cited by 154
Vilaça-Faria, H., Salgado, A. J., & Teixeira, F. G. (2019) · Cells · doi:10.3390/cells8020118 · Cited by 157
“Indeed, Vizoso and colleagues [115] have recently proposed that MSCs-derived secretome is sufficient to significantly improve multiple biomarkers of the pathophysiology, making it a potential strategy to be used for the establishment and identification of promising PD biomarkers.”
BackgroundLi, X., Wang, Y., Shi, L., Li, B., Li, J., Wei, Z., Lv, H., Wu, L., Zhang, H., Yang, B. J., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00670-x · Cited by 162
Boido, M., Ghibaudi, M., Gentile, P., Favaro, E., Fusaro, R., & Tonda‐Turo, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-42848-w · Cited by 157
Current Strategies to Enhance Adipose Stem Cell Function: An Update
Seo, Y., Shin, T., & Kim, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153827 · Cited by 157
“Therefore, the therapeutic actions of MSC-EVs are largely dependent on their tissue regenerative and immunomodulatory capacity as MSCs (Table 4) [214,215].”
BackgroundExtracellular Vesicle Heterogeneity and Its Impact for Regenerative Medicine Applications
van de Wakker, S. I., Meijers, F. M., Sluijter, J. P. G., & Vader, P. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000841 · Cited by 155
“For this reason, tissue regeneration using stem cell–derived EVs has been studied intensively and is showing great potential for therapeutic applications (Lai et al., 2010; Liang et al., 2014; Vizoso et al., 2017).”
BackgroundPalumbo, P., Lombardi, F., Siragusa, G., Cifone, M. G., Cinque, B., & Giuliani, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071897 · Cited by 147
“ASCs are considered a promising tool for regenerative medicine mainly for their ability to secrete a wide range of bioactive factors as well as extracellular vesicles, able to affect both local and systemic physiological processes [32].”
BackgroundExosome in Cardiovascular Diseases: A Complex World Full of Hope
Bellin, G., Gardin, C., Ferroni, L., Chachques, J. C., Rogante, M., Mitrečić, D., Ferrari, R., & Zavan, B. (2019) · Cells · doi:10.3390/cells8020166 · Cited by 148
“This means that the secretion, content, and function of EXOs strongly vary in response to changes in the cell microenvironment [4].”
BackgroundHypoxia-Conditioned Mesenchymal Stem Cells in Tissue Regeneration Application
Yang, Y., Lee, E. H., & Yang, Z. (2021) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0145 · Cited by 153
“88 VEGF and TGF-b 1 regulate PI3K/Akt and TGF-b / SMAD2 pathways, 89,90 while inhibition of either of these pathways can reduce the migration of fibroblasts.”
Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics
Seo, Y., Kim, H., & Hong, I. (2019) · Stem Cells International · doi:10.1155/2019/5126156 · Cited by 147
“In recent years, MSC secretome analyses have shown that MSCs can produce various chemokines, growth factors, and other signaling molecules affecting polarization, maturation, proliferation, and migration of macrophage [65, 66] and growing evidence supports that MSC-EVs also recapitulate the beneficial effect of MSCs o…”
BackgroundDental Pulp Stem Cell-Derived Secretome and Its Regenerative Potential
Bar, J. K., Lis-Nawara, A., & Grelewski, P. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112018 · Cited by 142
“In the last decade, stem cells have been proposed for use in regenerative medicine, with attention focused on mesenchymal stem cells (MSCs) as a promising therapeutic option in regenerative medicine and tissue engineering due to their regenerative and protective abilities [1].”
BackgroundInfluentialHaider, K. H., & Aramini, B. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1548-7 · Cited by 139
“The exosome-based strategy is fast-emerging as an alternative to the conditioned medium-based cell-free therapy approach [132].”
BackgroundMesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review
Hoogduijn, M. J., & Lombardo, E. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0073 · Cited by 151
Bodart‐Santos, V., de Carvalho, L. R. P., de Godoy, M. A., Batista, A. F., Saraiva, L. M., Lima, L. G., Abreu, C. A., Felice, F. G. D., Galina, A., Méndez‐Otero, R., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1432-5 · Cited by 150
Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy
Fan, M., Pi, J.-K., Zou, C., Jiang, Y., Li, Q., Zhang, X., Xing, F., Nie, R., Chen, H., & Xie, H. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.04.007 · Cited by 208
“As non-hematopoietic multipotent stem cells with self-renewal and multi-lineage differentiation capabilities, the MSCs stand among the most crucial types of adult stem cells and have found application in cell therapy for various diseases [84,85].”
BackgroundXiong, M., Zhang, Q., Hu, W., Zhao, C., Lv, W., Yi, Y., Wu, Y., & Wu, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.574223 · Cited by 143
Moshy, S. E., Radwan, I. A., Rady, D., Abbass, M. M. S., El‐Rashidy, A. A., Sadek, K. M., Dörfer, C. E., & El‐Sayed, K. M. F. (2020) · Stem Cells International · doi:10.1155/2020/7593402 · Cited by 139
“It can be accurately gauged for proper dosages and produced in large quantities, using cell lines without subjecting the patient to invasive extraction procedures, which is both time and cost saving [28 – 31].”
Nooshabadi, V. T., Mardpour, S., Yousefi‐Ahmadipour, A., Allahverdi, A., Izadpanah, M., Daneshimehr, F., Ai, J., Banafshe, H. R., & Ebrahimi‐Barough, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26726 · Cited by 133
“Further studies indicates that exosomes derived from cardiac progenitor cells mollify cardiomyocyte death in a murine model of ischemic-reperfusion.(234,237) Besides, cardiospherderived cells release exosomes that exert the same regenerative effect as their cells of origin in left ventricular dysfunction.”
Mesenchymal stem cells secretome: current trends and future challenges
Teixeira, F. G., & Salgado, A. J. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.264455 · Cited by 138
“, 2016)), providing a convenient source of bioactive factors; fifth, in the form of conditioned media, MSCs secretome use is more economical and practical for clinical applications, as it avoids invasive cell collection procedures; sixth, MSCs secretome obtained for therapeutic applications could be modified to desire…”
InfluentialGriffin, K. H., Fok, S. W., & Leach, J. K. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00266-z · Cited by 146
Thomi, G. F., Joerger-Messerli, M. S., Haesler, V., Muri, L., Surbek, D., & Schoeberlein, A. (2019) · Cells · doi:10.3390/cells8080855 · Cited by 133
“MSC-EV hold great therapeutic potential in PBI as they exhibit similar neuroprotective and -regenerative potential as their mother cells [30].”
BackgroundFoo, J. B., Looi, Q. H., Chong, P. P., Hassan, N. H., Yeo, G. E. C., Ng, C. Y., Koh, B., How, C. W., Lee, S. H., & Law, J. X. (2021) · Stem Cells International · doi:10.1155/2021/2616807 · Cited by 155
“It was also reported that secretome has lower cell surface proteins compared to stem cells, which makes allogeneic secretome safer than allogeneic stem cells because of the lower risk of immunogenicity [184].”
BackgroundLu, D., Xu, Y., Liu, Q., & Zhang, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.681171 · Cited by 146
“, 2018) and the maturation, differentiation, proliferation and functional activation of peripheral blood mononuclear cells (PBMCs) by secreting regulatory molecules and cytokines (Di Nicola et al., 2002; da Silva Meirelles et al., 2006; Gazdic et al., 2015; Vizoso et al., 2017).”
BackgroundTherapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
Harrell, C. R., Jovicic, N. U., Djonov, V., & Volarević, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050474 · Cited by 138
“MSC‐Exos have lipid bilayers enriched with integrins and ligands for cell surface receptors [11].”
BackgroundImmunomodulation of MSCs and MSC-Derived Extracellular Vesicles in Osteoarthritis
Zhao, X., Zhao, Y., Sun, X., Xing, Y., Wang, X., & Yang, Q. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.575057 · Cited by 134
“Immunomodulatory Effect of MSCs on Macrophages MSCs can produce various growth factors, chemokines, and other signaling molecules affecting macrophage polarization, maturation, proliferation, and migration, which have been verified by MSC secretome analyses (Vizoso et al., 2017; Lin and Du, 2018).”
BackgroundBari, E., Perteghella, S., Catenacci, L., Sorlini, M., Croce, S., Mantelli, M., Avanzini, M. A., Sorrenti, M., & Torre, M. L. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0240 · Cited by 127
Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics
Zhu, Y., Ge, J., Huang, C., Liu, H., & Jiang, H. (2021) · Theranostics · doi:10.7150/thno.46436 · Cited by 132
“At such, the anti-inflammatory microenvironments induced by transplanted MSCs help promote neurogenesis and prevent neural degeneration [78, 81].”
BackgroundRole of Exosomes as a Treatment and Potential Biomarker for Stroke
Otero-Ortega, L., Laso-García, F., Gómez-de Frutos, M., Fuentes, B., Diekhorst, L., Díez-Tejedor, E., & Gutiérrez-Fernández, M. (2019) · Translational Stroke Research · doi:10.1007/s12975-018-0654-7 · Cited by 105
Bari, E., Ferrarotti, I., Torre, M. L., Corsico, A. G., & Perteghella, S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.022 · Cited by 122
Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis
Sarsenova, M., Issabekova, A., Abisheva, S., Rutskaya-Moroshan, K., Ogay, V. B., & Saparov, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111592 · Cited by 133
Qiu, J., Wang, X., Zhou, H., Zhang, C., Wang, Y., Huang, J., Liu, M., Yang, P., & Song, A. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1546-9 · Cited by 119
“Conditioned medium generated by MSC culture contains growth factors, cytokines, and other active substances [13].”
BackgroundShape-Memory Polymers Hallmarks and Their Biomedical Applications in the Form of Nanofibers
Pisani, S., Genta, I., Modena, T., Dorati, R., Benazzo, M., & Conti, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031290 · Cited by 123
“Accumulating evidence suggests that MSCs act through a combination of paracrine cell signaling and cell transdifferentiation, enhancing wound regeneration and improving angiogenesis [73,74].”
BackgroundQi, T., Weng, J., Yu, F., Zhang, W., Li, G., Qin, H., Tan, Z., & Zeng, H. (2021) · Biological Trace Element Research · doi:10.1007/s12011-020-02183-y · Cited by 115
“More and more reports have shown that MSCs have anti-inflammatory properties [11] and are effective in tissue regeneration [12] by paracrine human mesenchymal stem cell exosomes (hMSC-exosomes) [13].”
BackgroundRoshanbinfar, K., Mohammadi, Z., Mesgar, A. S.-M., Dehghan, M. M., Oommen, O. P., Hilborn, J. G., & Engel, F. B. (2019) · Biomaterials Science · doi:10.1039/c9bm00434c · Cited by 118
He, J., Liu, J., Huang, Y., Tang, X., Xiao, H., & Hu, Z. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.641157 · Cited by 122
Dental Pulp Stem Cell-Derived Conditioned Medium: An Attractive Alternative for Regenerative Therapy
Kichenbrand, C., Velot, É., Menu, P., & Moby, V. (2018) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2018.0168 · Cited by 126
“14 Se-cretome is contained in the conditioned medium (CM) in vitro .”
The impact of cryopreservation on bone marrow-derived mesenchymal stem cells: a systematic review
Bahsoun, S., Coopman, K., & Akam, E. C. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02136-7 · Cited by 134
Lu, X., Wu, Z., Xu, K., Wang, X., Wang, S., Qiu, H., Li, X., & Chen, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.783816 · Cited by 113
Wang, C., Hu, Q., Song, W. D., Yu, W., & He, Y. (2020) · The American Journal of Sports Medicine · doi:10.1177/0363546520908847 · Cited by 116
“Based on these results, ASC-Exos may be used as a ‘‘cell-free’’ therapeutic alternative to stem cell–based clinical therapies with the consideration of its advantage over stem cells.(1,33) The enhanced tendon-bone healing in the ASC-Exos group may be ascribed to 2 aspects.”
Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration
Lin, H., Chen, H., Zhao, X., Chen, Z. B., Zhang, P., Tian, Y., Wang, Y., Ding, T., Wang, L., & Shen, Y. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03125-5 · Cited by 115
Chouaib, B., Haack‐Sørensen, M., Chaubron, F., Cuisinier, F., & Collart-Dutilleul, P.-Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612594 · Cited by 117
Ling, X., Zhang, G., Xia, Y., Zhu, Q., Zhang, J., Li, Q., Niu, X., Hu, G., Yang, Y., Wang, Y., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14774 · Cited by 109
Mu, J., Li, L., Wu, J., Huang, T., Zhang, Y., Cao, J. X., Ma, T., Chen, J., Zhang, C., Zhang, X., et al. (2022) · Biomaterials Science · doi:10.1039/d1bm01722e · Cited by 114
Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis
Mathew, S. A., Naik, C., Cahill, P. A., & Bhonde, R. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03268-1 · Cited by 111
Lu, J., Yang, J., Zheng, Y., Chen, X., & Fang, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52513-x · Cited by 116
Cell Interplay in Osteoarthritis
Li, Z., Huang, Z., & Bai, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.720477 · Cited by 128
Vizoso, F. J., Eiró, N., Costa, L. A., Esparza, P., Landín, M., Díaz‐Rodríguez, P., Schneider, J., & Pérez-Fernández, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153738 · Cited by 109
“The use of MSC-derived secretome products offers key advantages over applications based on stem cells themselves [6].”
BackgroundSelf-citationLiao, Z., Liu, C., Wang, L., Sui, C., & Zhang, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665645 · Cited by 114
Adipose-Derived Stem Cell Exosomes Promoted Hair Regeneration
Wu, J., Yang, Q., Wu, S., Yuan, R., Zhao, X., Li, Y., Wu, W., & Zhu, N. (2021) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00347-y · Cited by 109
Eiró, N., González, L. O., Fraile, M., Cid, S., Schneider, J., & Vizoso, F. J. (2019) · Cancers · doi:10.3390/cancers11050664 · Cited by 113
“The use of cell-free therapies such as MSC-sourced secretome in regenerative medicine provides key advantages over stem-cell based applications [226]: its application resolves several safety considerations potentially associated with the transplantation of living and proliferating cell populations (immune compatibilit…”
BackgroundSelf-citationMendes-Pinheiro, B., Anjo, S. I., Manadas, B., Da Silva, J. D., Marote, A., Behie, L. A., Teixeira, F. G., & Salgado, A. J. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00294 · Cited by 103
“For instance, the time and cost of expansion and maintenance of cultured MSCs could be significantly reduced, and the storage can be done for long periods without loss of product potency and quality (Bermudez et al., 2015, 2016; Vizoso et al., 2017).”
BackgroundInfluentialMesenchymal Stem Cells-Derived Exosomes for Wound Regeneration
Goodarzi, P., Larijani, B. A., Alavi-Moghadam, S., Tayanloo-Beik, A., Mohamadi-Jahani, F., Ranjbaran, N., Payab, M., Falahzadeh, K., Mousavi, M., & Arjmand, B. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_251 · Cited by 114
Villatoro, A. J., Alcoholado, C., Martín‐Astorga, M. D. C., Fernández, V., Cifuentes, M., & Becerra, J. (2018) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2018.12.003 · Cited by 102
“and complex mixture of different soluble factors (mainly growth factors, cytokines, chemokines and extracellular matrix components) and a variety of extracellular vesicles including exosomes, microvesicles and apoptotic bodies, and can be found in the medium where the stem cells are cultured (conditioned medium, CM) (…”
BackgroundCai, G., Cai, G., Zhou, H., Zhuang, Z., Liu, K., Pei, S., Wang, Y., Wang, H., Wang, X., Xu, S., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02030-w · Cited by 101
“MiR-133b overexpressed in exosomes secreted by MSCs can promote the recovery of nerve function and increase nerve plasticity by stimulating secondary secretion of exosomes from astrocytes [52].”
BackgroundRetractedPulido-Escribano, V., Torrecillas-Baena, B., Camacho-Cardeñosa, M., Dorado, G., Gálvez-Moreno, M. Á., & Casado‐Díaz, A. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i7.453 · Cited by 112
Babajani, A., Soltani, P., Jamshidi, E., Farjoo, M. H., & Niknejad, H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00748 · Cited by 99
“…epidermal growth factor receptor, periostin, ANG1, PDGF, insulinlike growth factor, and IL-6 (Shangguan et al., 2012; Ye et al., 2012; Akimoto et al., 2013; Lee et al., 2013; Lin et al., 2013; Kansy et al., 2014; Hossain et al., 2015; Wolfe et al., 2016; Wang et al., 2018; Wang Y. et al., 2019).”
BackgroundMohammed, E., Khalil, E., & Sabry, D. (2018) · Biomolecules · doi:10.3390/biom8040167 · Cited by 99
“is mediated by internalization of them into the targeted cells, where they have the same therapeutic effects as MSCs, including trophic activity, angiogenic effect, antiapoptic effect, immunemodulatory, and antimicrobial effects [13].”
BackgroundGualerzi, A., Kooijmans, S. A. A., Niada, S., Picciolini, S., Brini, A. T., Camussi, G., & Bedoni, M. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1568780 · Cited by 103
Fernández-Francos, S., Eiró, N., Costa, L. A., Escudero-Cernuda, S., Fernández‐Sánchez, M. L., & Vizoso, F. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073576 · Cited by 106
“It is also key that MSC secrete MMPs, in particular MMP1, which has a role in tissue invasion in order to permit that MSC can traverse the endothelial basement membrane [110].”
BackgroundInfluentialSelf-citationCell secretome: basic insights and therapeutic opportunities for CNS disorders
Pinho, A. G., Cibrão, J. R., Silva, N. A., Monteiro, S., & Salgado, A. J. (2020) · Pharmaceuticals · doi:10.3390/ph13020031 · Cited by 94
“Currently, this definition could be updated since it is known that, beyond soluble factors, the secretome also has the presence of lipids and extracellular vesicles (EVs) carrying important molecules [32,33].”
BackgroundStem Cell Therapies in Kidney Diseases: Progress and Challenges
Rota, C., Morigi, M., & Imberti, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112790 · Cited by 99
Zhang, L., Ma, X.-J.-N., Fei, Y.-Y., Han, H., Xu, J., Cheng, L., & Li, X. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108004 · Cited by 99
Lombardi, F., Palumbo, P., Augello, F. R., Cifone, M. G., Cinque, B., & Giuliani, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153721 · Cited by 101
Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
Gugliandolo, A., Bramanti, P., & Mazzon, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228662 · Cited by 101
Pathophysiology of Preeclampsia: The Role of Exosomes
Matsubara, K., Matsubara, Y., Uchikura, Y., & Sugiyama, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052572 · Cited by 100
“MSCs are used in regenerative medicine, and their pleiotropic effects are reportedly mediated in a paracrine manner [86].”
BackgroundMolecular Mechanisms of Kidney Injury and Repair
Rayego‐Mateos, S., Márquez‐Expósito, L., Rodrigues‐Díez, R., Sanz, A. B., Guiteras, R., Doladé, N. G., Rubio-Soto, I., Manonelles, A., Codina, S., Ortíz, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031542 · Cited by 103
“In this regard, MSC-derived EVs represent an alternative to MSC-based therapies that overcome most of the problems associated with MSC transplantation but retain the beneficial effects [190].”
BackgroundMesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges
Najar, M., Bouhtit, F., Melki, R., Afif, H., Hamal, A., Fahmi, H., Merimi, M., & Lagneaux, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050626 · Cited by 94
“Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life, and their potential as a ready-to-go biologic product [29].”
Background
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.